Page last updated: 2024-12-08

5-hydroxytryptoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5-hydroxytryptoline: results from the action of an enzymatic preparation from human brain on 5-hydroxytryptamine; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159959
CHEBI ID69060
SCHEMBL ID2396914
MeSH IDM0054741

Synonyms (23)

Synonym
5-hydroxytetrahydro-beta-carboline
5-hydroxytryptoline
plectocomine
6-hydroxytetrahydronorharmane
brn 0643872
1h-pyrido(3,4-b)indol-6-ol, 2,3,4,9-tetrahydro-
2,3,4,9-tetrahydro-1h-pyrido(3,4-b)indol-6-ol
2,3,4,9-tetrahydro-1h-pyrido[3,4-b]indol-6-ol
23778-34-9
6-hydroxytetrahydro-beta-carboline
AKOS006276799
5-23-12-00046 (beilstein handbook reference)
CHEBI:69060
AB09761
HASNCBJLQYTILW-UHFFFAOYSA-N
2,3,4,9-tetrahydro-1h-beta-carbolin-6-ol
SCHEMBL2396914
DTXSID30178463
6-hydroxy-tetrahydronorharmane
Q27137401
1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol
C90436
EN300-1116931
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
beta-carbolinesAny pyridoindole containing a beta-carboline skeleton and their hydrogenated derivatives
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-199010 (90.91)18.7374
1990's1 (9.09)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.79 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]